mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.0015 |
1 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00094 |
1 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00084 |
1 |
mRNA |
Cyclopamine |
FIMM |
pan-cancer |
AAC |
-0.0041 |
1 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00066 |
1 |
mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
-0.00076 |
1 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.00081 |
1 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00066 |
1 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.00064 |
1 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.00062 |
1 |